Who can administer
May be administered by registered competent doctor or nurse/midwife
Important information
Unlicensed preparation
Available preparations
Isoniazid 300mg in 5ml ampoules (Cemidon)
Reconstitution
Not required - already in solution
Draw up using a 5 micron filter needle
Methods of intravenous administration
Bolus intravenous injection
- Administer undiluted
- Give slowly over 3 to 5 minutes
Dose in adults
Tuberculosis, in combination with other drugs (standard unsupervised 6-month treatment)
- Give 300mg daily (initial and continuation phases)
Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive
Monitoring
- Note: Cemidon contains sodium metabisulfite which may cause allergic reactions
- Baseline liver enzymes not routinely recommended in latent TB except for patients with HIV, liver disease, immediate post-partum < 3 months, or regular alcohol use (ref 3)
- Baseline liver enzymes recommended in treatment of active TB; repeat liver function tests monthly if:
- abnormalities at baseline
- symptoms consistent with hepatotoxicity develop
- patients chronically consume alcohol
- patients take other potentially hepatotoxic medications
- patients have viral hepatitis or history of liver disease, human immunodeficiency virus (HIV) infection, or prior drug-induced liver injury (ref 3)
- If no evidence of liver disease (and pre-treatment liver function is normal), further checks are only necessary if the patient develops fever, malaise, vomiting, jaundice or unexplained deterioration during treatment.
- Monitor: for skin reactions, temperature, liver function (weekly for the first month, then monthly) (ref 1)
- Caution: numerous drug interactions (ref 3)
Further information
- Give oral pyridoxine to reduce the risk of peripheral neuropathy occurring (ref 2)
- At low temperatures, isoniazid in solution may crystallise; warm the injection to room temperature to re-dissolve the crystals before use (ref 2)
- Injection solution is given undiluted. However, it is known to be compatible with Sodium chloride 0.9%
Storage
Store below 250C
References
1. BNF - medicinescomplete.com. Accessed Oct 30th 2024
2. Medusa NHS Injectable Medicines Guide. Accessed Oct 30th 2024
3. Sanford Guide. Accessed Oct 30th 2024
Therapeutic classification
Antimycobacterial